¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° - ¿¹Ãø(-2029³â)
Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2029
»óǰÄÚµå : 1623606
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 412 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,621,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,792,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ±Ô¸ð´Â 2024³â 58¾ï 5,000¸¸ ´Þ·¯¿¡¼­ 2029³â 77¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 6.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÇÇè½Ç ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ³ôÀº 󸮷® °Ë»çÀÇ Çʿ伺, ¿À¹Í½º ¿¬±¸ Áõ°¡, ½ÇÇè½Ç ÀýÂ÷¿¡¼­ º¸´Ù Á¤È®ÇÏ°í ºü¸¥ °á°úÀÇ Çʿ伺 µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÁöÃâÀ» ¿ä±¸ÇÏ°í ´õ ºü¸¥ Áø´ÜÀÇ Çʿ伺À» °¡Á®¿Í ÀÚµ¿È­ äÅÃÀ» Áõ°¡½Ãų °ÍÀÔ´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó³âµµ 2022-2029³â
±âÁØ ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2029³â
°ËÅä ´ÜÀ§ ±Ý¾×(¹ÌÈ­)
ºÎ¹®º° Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿/¾ÆÇÁ¸®Ä«

¿¹Ãø ±â°£ µ¿¾È ÀÚµ¿ ¿öÅ©½ºÅ×ÀÌ¼Ç ºÐ¾ß°¡ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ Á¦Ç°±ºÀº °£¼ÒÈ­µÈ ¿öÅ©½ºÅ×À̼Ç, Çâ»óµÈ Á¤È®µµ, ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡ °ÉÄ£ ¹Ýº¹¼ºÀ» ÅëÇØ ½ÇÇè½Ç ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ÀÚµ¿È­ ¿öÅ©½ºÅ×ÀÌ¼Ç Á¦Ç°ÀÇ °æ¿ì, ¾×ü Ãë±Þ ¿öÅ©½ºÅ×ÀÌ¼Ç Á¦Ç°Àº ÇöÀç PCR, qPCR, Â÷¼¼´ë ½ÃÄö½Ì µî ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡ ÇʼöÀûÀÎ ½Ã·á ¹× ½Ã¾àÀÇ °íÁ¤¹Ð À̼ۿ¡ °¡Àå ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä ÇÏÀ§ ºÎ¹®Àº ¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ® ¸®´õ±âÀÔ´Ï´Ù. ºÐ¼®¿¡¼­ ³ôÀº 󸮷®ÀÇ ½ºÅ©¸®´× ¹× Á¤·®È­¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ½Å¾à °³¹ß ¹× »ý¹°ÇÐÀû ¿¬±¸ ¼Óµµ¸¦ Å©°Ô ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÚµ¿ ELISA ½Ã½ºÅÛÀº ¸é¿ª ÃøÁ¤¿¡ ½Ã°£ÀÌ ¸¹ÀÌ °É¸®´Â ÇÁ·ÎÅäÄÝÀ» ÀÚµ¿È­Çϱ⠶§¹®¿¡ ³ôÀº ¼ö¿ä°¡ ÀÖ½À´Ï´Ù. ÀÚµ¿ ELISA ½Ã½ºÅÛÀº ¸ðµç ¸é¿ª ÃøÁ¤ ÇÁ·ÎÅäÄÝÀ» ¼öÇàÇϱ⠶§¹®¿¡ Áø´Ü ¹× ÀÓ»ó °Ë»ç¿¡ ¼Ò¿äµÇ´Â ½Ã°£À» Å©°Ô ´ÜÃàÇϰí Ãâ·ÂÀÌ ºü¸£°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç ¼öµ¿ ÀÔ·ÂÀÇ °³ÀÔÀ» ÃÖ¼ÒÈ­ ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ÀÚµ¿ ÇÙ»ê Á¤Á¦ ½Ã½ºÅÛÀº ºÐÀÚ »ý¹°ÇÐ ¹× À¯Àüü ¿¬±¸¿¡¼­ DNA ¹× RNA ÃßÃâ ¹× Á¤Á¦ °úÁ¤À» °¡¼ÓÈ­Çϰí Ãß°¡ ÀÀ¿ëÀ» À§ÇØ ÇÊ¿äÇÑ °ÍÀ¸·Î °£Áֵ˴ϴÙ. ÀÌ·¯ÇÑ ÇÏÀ§ ºÎ¹®¿¡ ´ëÇÑ Á¶»ç´Â È¿À²¼º°ú µ¥ÀÌÅÍ Ç°Áú Çâ»ó¿¡ ´ëÇÑ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀÇ °ü½ÉÀ» º¸¿©ÁÝ´Ï´Ù.

½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀåÀº º´¿ø ¹× Áø´Ü ½ÇÇè½Ç, Á¦¾à ¹× »ý¸í °øÇÐ ±â¾÷, ¿¬±¸ ¹× Çмú ±â°ü, ȯ°æ Å×½ºÆ® ½ÇÇè½Ç, ¹ýÀÇÇÐ ½ÇÇè½Ç, ½ÄÀ½·á »ê¾÷À¸·Î ¼¼ºÐÈ­µÇ¸ç, 2023³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â º´¿ø ¹× Áø´Ü ½ÇÇè½ÇÀÔ´Ï´Ù. ÀÌ´Â ÁÖ·Î ´Ù¾çÇÑ º¹ÀâÇÑ °Ë»ç¸¦ ÇÊ¿ä·Î ÇÏ´Â ¸¹Àº ȯÀÚ¸¦ Ä¡·áÇϱâ À§ÇØ Ã³¸®·®, Á¤È®µµ ¹× ºü¸¥ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ´Â ÀÚµ¿È­ ¼Ö·ç¼ÇÀÌ ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí, ó¸® ½Ã°£À» ÃÖ¼ÒÈ­Çϸç, Á¤È®µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖµµ·Ï Çϱâ À§ÇÔÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÌ¸ç ¼ºÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷ÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÁýÁß, ÀÌ Áö¿ªÀÇ Àα¸ Áõ°¡¿¡ µû¸¥ È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ÀΰøÁö´É°ú ·Îº¿ °øÇÐÀÇ ¹ßÀüÀº ´Ù¸¥ ºÎ¹®ÀÇ ½ÇÇè½Ç ÀÚµ¿È­¸¦ µ½°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, Á¦Ç°º°/¿ëµµº°/ÃÖÁ¾ »ç¿ëÀÚº°/Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÑ º¸°í¼­ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÇÁ¸®¹Ì¾ö ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, Á¦Ç°º°

Á¦7Àå ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ¿ëµµº°

Á¦8Àå ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, Áö¿ªº°

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global lab automation market is projected to reach USD 7.71 Billion by 2029 from USD 5.85 Billion in 2024, growing at a CAGR of 6.9% during the forecast period. Some of the primary drivers for the lab automation solutions include the need for high-throughput testing, an increase in omics research, and the need for more precise and faster results in laboratory procedures. Moreover, an increase in the prevalence of chronic diseases necessitates expenditure in research and development and need for faster diagnosis, which increases the adoption of automation.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"Automated Workstation to register largest market share in 2023"

The automated workstation segment will lead the lab automation market during the forecast period. This product line helps optimize the laboratory workflow through streamlined workstations, and increased precision, and reproducibility across many applications. In the case of the automated workstation product, liquid-handling workstation products are currently most commonly used for high-accuracy transfer of samples and reagents that are vital in a variety of applications involving PCR, qPCR, next-generation sequencing, etc. Another major sub-segment is microplate readers. It enables high-throughput screening and quantification in assays, thus significantly speeding up drug discovery and biological research. Automated ELISA systems are in high demand because they automate the protocols that take time to run through immunoassays. Automated ELISA systems save diagnostics and clinical laboratories lots of time because it does all the immunoassay protocols, hence the output is rapid and reliable, minimizing the involvement of manual inputs. Apart from that, automated nucleic acid purification systems are considered necessary for molecular biology and genomics research to speed up DNA and RNA extraction and purification processes for further applications. Growth in these sub-segments is indicative of the interest of the lab automation market toward increasing efficiency and data quality, which are now crucial factors in all pharmaceutical, diagnostic, and research settings.

"Hospitals & diagnostic laboratories segment held the largest share of Lab Automation market in 2023, by End-user."

The market by end-users of the lab automation market is further divided into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, research and academic institutes, environmental testing laboratories, forensic laboratories, and the food and beverage industry. The largest share in 2023 would be hospitals and diagnostic laboratories mainly due to increasing demand for throughput, accuracy, and high-speed diagnostics solutions to treat more patients requiring a variety of complex tests. This will ensure automation solutions simplify workflows, minimize turnaround times, and improve accuracy.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The Asia Pacific region will be the leader in growth in the lab automation market, with the highest rate during the forecast period. It will be driven by increased investment in healthcare infrastructure, research and development emphasis by the pharmaceutical and biotechnology industries, and increased demand for efficient diagnostic solutions for this region's increasing population. In addition, developments in artificial intelligence and robotics are assisting the laboratories within other sectors to become more automated.

A breakdown of the primary participants referred to for this report is provided below:

Prominent players in the Lab Automation market include: Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomerieux (France), Hamilton Company (US), Hudson Robotics (US) .

Research Coverage

The market is categorized by the product, application, end-user, and region. Factors affecting the lab automation market-including drivers, restraints, opportunities, and challenges are also discussed in the report. The report provides a perspective of opportunities and challenges ahead for stakeholders, besides profiling the details of leading players' competitive landscape. The micro-markets are further segregated by focusing on growth trends, prospects, and contributions of these trends to the lab automation market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.

Key Benefits of Buying this Report

This report is to be benefitted by new and existing players. It will give deep information about the lab automation market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Owing to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas. Further, this report supplies critical trends, challenges, growth drivers, and opportunities that complete the strategic decision-making process with a well-balanced analysis.

Through this report, readers get insightful views into the following parameters:

Analysis of the key growth drivers, restraints, challenges, and opportunities influencing market growth for lab automation market. The major driving forces behind lab automation market are an increase in chronic diseases. Requirement for rapid and precise diagnostic tools enhances demand for automation solutions. Technologically, the development of rapid and automated testing systems supports market growth by increasing efficiency and accuracy in tests.

Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products and services in the antimicrobial susceptibility testing market.

Market Development: Further, the report has elaborated the markets by segmenting the lab automation market into different regions

Market Diversification: New product launches, unexploited markets, recent developments, investments in the lab automation market.

Competitive Analysis: Exhaustive study of market share, service offering leading strategies of major players such as Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomerieux (France), Hamilton Company (US), Hudson Robotics (US) .

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 LAB AUTOMATION MARKET, BY PRODUCT

7 LAB AUTOMATION MARKET, BY APPLICATION

8 LAB AUTOMATION MARKET, BY END USER

9 LAB AUTOMATION MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â